Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laura Gault, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 22944
Pleven, Bulgaria
- Site Reference Id/investigator# 22942
Plovdiv, Bulgaria
- Site Reference Id/investigator# 22945
Sofia, Bulgaria
- Site Reference Id/investigator# 22946
Sofia, Bulgaria
- Site Reference Id/investigator# 20276
Litoměřice, Czechia
- Site Reference Id/investigator# 20273
Pilsen, Czechia
- Site Reference Id/investigator# 20272
Prague, Czechia
- Site Reference Id/investigator# 20274
Prague, Czechia
- Site Reference Id/investigator# 20701
Prague, Czechia
- Site Reference Id/investigator# 23624
Bratislava, Slovakia
- Site Reference Id/investigator# 23625
Bratislava, Slovakia
- Site Reference Id/investigator# 23622
Michalovce, Slovakia
- Site Reference Id/investigator# 23942
Rimavská Sobota, Slovakia
- Site Reference Id/investigator# 20267
Belville, South Africa
- Site Reference Id/investigator# 20266
Cape Town, South Africa
- Site Reference Id/investigator# 20261
Durban, South Africa
- Site Reference Id/investigator# 21682
George, South Africa
- Site Reference Id/investigator# 20265
Johannesburg, South Africa
- Site Reference Id/investigator# 20271
Port Elizabeth, South Africa
- Site Reference Id/investigator# 20263
Richards Bay, South Africa
- Site Reference Id/investigator# 20187
Blackburn, United Kingdom
- Site Reference Id/investigator# 20183
Bradford, United Kingdom
- Site Reference Id/investigator# 20191
Crowborough, United Kingdom
- Site Reference Id/investigator# 20184
Glasgow, United Kingdom
- Site Reference Id/investigator# 20190
London, United Kingdom
- Site Reference Id/investigator# 20192
Southampton, United Kingdom
- Site Reference Id/investigator# 19904
Fresno, California, United States
- Site Reference Id/investigator# 23025
West Palm Beach, Florida, United States
- Site Reference Id/investigator# 19905
Indianapolis, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 30 Nov 2010
- Completion
- 30 Nov 2010
- Last update posted
- 31 Jan 2013
- Registered enrollment
- 274
- Registry id
- NCT00948909
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.